Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-contro
暂无分享,去创建一个
Alexander Fraser | Philip G Conaghan | Paul Emery | Adam Greenstein | Andrew Brown | P. Emery | M. Quinn | P. Conaghan | P. O'connor | C. Brown | A. Fraser | A. Greenstein | Philip J O'Connor | Z. Karim | Zunaid Karim | Mark A Quinn | Clare Brown | Stephen Jarret | A. Brown | Stephen Jarret
[1] R N Maini,et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. , 2000, The New England journal of medicine.
[2] P. Mease,et al. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial , 2000, The Lancet.
[3] P. Rutgeerts,et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. , 1999, The New England journal of medicine.
[4] Marcin Szkudlarek,et al. New radiographic bone erosions in the wrists of patients with rheumatoid arthritis are detectable with magnetic resonance imaging a median of two years earlier. , 2003, Arthritis and rheumatism.
[5] P. Emery,et al. Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention. , 2003, Clinical and experimental rheumatology.
[6] P. Emery,et al. Early rheumatoid arthritis: time to aim for remission? , 1995, Annals of the rheumatic diseases.
[7] Désirée van der Heijde,et al. Plain X-rays in rheumatoid arthritis: overview of scoring methods, their reliability and applicability. , 1996 .
[8] S. van der Linden,et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis , 1997, The Lancet.
[9] J J Anderson,et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. , 1995, Arthritis and rheumatism.
[10] F. Arnett. Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.
[11] Michael J. Green,et al. Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis. , 2003, Arthritis and rheumatism.
[12] E C Coles,et al. Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis. , 2000, Arthritis and rheumatism.
[13] M. Prevoo,et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. , 1995, Arthritis and rheumatism.
[14] S. Soraci,et al. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. , 1983, Arthritis and rheumatism.
[15] Richard W. Martin,et al. Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes. , 2002, Arthritis and rheumatism.
[16] M. V. van Leeuwen,et al. Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression. , 1998, British Journal of Rheumatology.
[17] H. Zeidler,et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial , 2002, The Lancet.
[18] M Ostergaard,et al. Magnetic resonance imaging-determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis. , 1999, Arthritis and rheumatism.
[19] D. Hommes,et al. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. , 2003, Gastroenterology.
[20] P. Emery,et al. Long-term treatment of rheumatoid arthritis with tumour necrosis factor alpha blockade: outcome of ceasing and restarting biologicals. , 2003, Rheumatology.
[21] P. Emery,et al. The therapeutic approach of early intervention for rheumatoid arthritis: what is the evidence? , 2001, Rheumatology.
[22] M. Boers. Understanding the window of opportunity concept in early rheumatoid arthritis. , 2003, Arthritis and rheumatism.
[23] R. Holder,et al. The acute phase and function in early rheumatoid arthritis. C-reactive protein levels correlate with functional outcome. , 1997, The Journal of rheumatology.
[24] P. Emery,et al. The Dunlop-Dottridge Lecture: prognosis in inflammatory arthritis: the value of HLA genotyping and the oncological analogy. , 1997, The Journal of rheumatology.
[25] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[26] M. V. van Leeuwen,et al. Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system. , 1997, The Journal of rheumatology.
[27] P. Rutgeerts,et al. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. , 1999, Gastroenterology.
[28] S. van der Linden,et al. Inflammation and damage in an individual joint predict further damage in that joint in patients with early rheumatoid arthritis. , 2001, Arthritis and rheumatism.
[29] J. Fries,et al. Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies. , 1996, Arthritis and rheumatism.
[30] Richard W. Martin,et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. , 2000, The New England journal of medicine.
[31] D. V. D. Heijde,et al. The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument. , 1997, British journal of rheumatology.
[32] P. Hannonen,et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial , 1999, The Lancet.